Agilent Technologies Stock News

Global Molecular Spectroscopy Market Synopsis: Research analysts accomplish smart, resourceful and engaging surveys while creating Molecular Spectroscopy Market report that are sure to provide the better results. By leveraging the use of smart strategies and formats, the report helps businesses gain

Equities research analysts predict that Agilent Technologies, Inc. (NYSE:A) will report earnings per share of $1.17 for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for Agilent Technologies earnings, with the highest EPS estimate coming in at $1.19 and the lowest estimate coming in at $1.16. Agilent Technologies posted earnings []

Global Biochips Market Overview: The top-notch Biochips Market research report has been structured by skilful and experienced team players who work hard to accomplish an absolute growth and success in the business. The Marketing report acts upon Market study and analysis

Atomic absorption spectroscopy (AAS) is a spectroanalytical procedure for the quantitative determination of chemical elements using the absorption of optical radiation (light) by free atoms in the gaseous state. The classification of Atomic Absorption Spectroscopy Instrument includes Flame, Graphite Furnace, Other.

Agilent Technologies (NYSE:A) had its price objective hoisted by Cowen from $180.00 to $187.00 in a report issued on Tuesday, Price Targets.com reports. They currently have an outperform rating on the medical research companys stock. A number of other analysts have also recently commented on A. SVB Leerink boosted their target price on shares of []

Agilent Technologies, Inc. (NYSE:A) Investment analysts at Jefferies Financial Group lowered their Q2 2022 EPS estimates for Agilent Technologies in a note issued to investors on Tuesday, November 23rd. Jefferies Financial Group analyst B. Couillard now expects that the medical research company will earn $1.07 per share for the quarter, down from their prior [] The post Agilent Technologies, Inc. Forecasted to Post Q2 2022 Earnings of $1.07 Per Share (NYSE:A) appeared first on ETF Daily News .

Agilent Technologies, Inc. (NYSE:A) Analysts at SVB Leerink lifted their Q1 2022 earnings per share estimates for Agilent Technologies in a report released on Monday, November 22nd. SVB Leerink analyst P. Souda now anticipates that the medical research company will post earnings per share of $1.17 for the quarter, up from their prior estimate []

Global Automated Liquid Handling Market Synopsis: Todays businesses choose the market research report solution such as Automated Liquid Handling Market report because it lends a hand with the improved decision making and more revenue generation. The report also aids in prioritizing

Agilent Technologies (NYSE:A) had its target price boosted by Cowen from $180.00 to $187.00 in a report issued on Tuesday, Analyst Ratings Network reports. They currently have an outperform rating on the medical research companys stock. Several other brokerages have also recently issued reports on A. Bank of America raised their price objective on Agilent []

Toxicology testing is a science that deals with the identification of poisons and controlled substances, and their effect on the legal, clinical, and industrial environment. Toxicology testing laboratories perform the diagnosis of numerous controlled substances for excessive consumption with the

Agilent Technologies (NYSE:A) updated its first quarter earnings guidance on Monday. The company provided EPS guidance of $1.16-1.18 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.16. The company issued revenue guidance of $1.64-1.66 billion, compared to the consensus revenue estimate of $1.66 billion.Agilent Technologies also updated its FY 2022 guidance []

DUBLIN--(BUSINESS WIRE)--The "Protein Stability Analysis Market Size By Product, By Technique, By End User, By Geographic Scope And Forecast" report has been added to ResearchAndMarkets.com''s offering. The global protein stability analysis market was valued at $2,354.76 Million in 2020 and is projected to reach USD 5,153.43 Million by 2028, growing at a CAGR of 10.10% from 2021 to 2028. Companies Mentioned Agilent Technologies Inc. Enzo Biochem Inc. GE Healthcare Shimadzu Corporation Thermo Fis

Agilent Technologies, Inc. (NYSE:A)s stock price gapped down before the market opened on Tuesday after an insider sold shares in the company. The stock had previously closed at $162.78, but opened at $155.73. Agilent Technologies shares last traded at $154.89, with a volume of 2,834 shares changing hands. Specifically, SVP Padraig Mcdonnell sold 1,500 shares []